Two studies suggest that T cells with stem-cell-like properties could work with antibody therapies to control HIV after a ...
On November 10, 2025, Imunon, Inc. (NASDAQ:IMNN) held an R&D day that featured presentations from ovarian cancer thought leaders and principal investigators from the Phase 3 OVATION 3 study and Phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback